(IN BRIEF) Fresenius Management SE has extended Sara Hennicken's term as Chief Financial Officer (CFO) until 2027, two years earlier…
(IN BRIEF) Fresenius Kabi announces FDA approval of Tyenne® (tocilizumab-aazg), the first tocilizumab biosimilar offering both IV and subcutaneous formulations.…
(IN BRIEF) Fresenius had a strong finish in 2023, with a robust fourth quarter performance. They project accelerated earnings growth…